JS111(AP-L1898 Capsules)

TERMINATED · PHASE1, PHASE2 · Lung Cancer

The study was stopped because of a change in the study strategy

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.